Simultaneous determination of prodrug of Ginkgolide B and Ginkgolide B in rat plasma by LC-MS/MS by Pan, Jian et al.
1167ISSN 0326-2383
KEY WORDS: Ginkgolide B, LC-MS/MS, Pharmacokinetics, Plasma, Prodrug of ginkgolide B.
* Author to whom correspondence should be addressed. E-mail: wu38331451@163.com
Latin American Journal of Pharmacy
(formerly Acta Farmacéutica Bonaerense)
Lat. Am. J. Pharm. 30 (6): 1167-72 (2011)
Regular Article
Received: September 27, 2010
Revised version: February 21, 2011
Accepted: February 24, 2011
Simultaneous Determination of Prodrug of Ginkgolide B
and Ginkgolide B in Rat Plasma by LC-MS/MS
Jian PAN, Zeyu WU*, Yuan YUAN, Ailing HUI & Yi YANG
Institute of Natural Medicine, Hefei University of Technology,
Hefei, 230009, People’s Republic of China
SUMMARY. A simple and sensitive liquid chromatography tandem mass spectrometry (LC-MS/MS)
method was established and validated for the determination of prodrug of ginkgolide B (PGB) and its
metabolite, ginkgolide B (GB) in rat plasma. The separation was achieved on a Waters Symmetry Shield
RP18 column (150 mm × 3.9 mm i.d., 5 μm particle size), using a mobile phase composed of methanol/wa-
ter with 10 mM ammonium acetate (85:15, v/v) at a flow rate of 800 μL/min in 2 min. An API 3200 triple
quadrupole mass spectrometer equipped with electrospray ionization source was operated in negative ion-
ization mode. Multiple reaction monitoring (MRM) was performed to quantify PGB, GB and the internal
standard (IS) at m/z transitions of 528.1 → 122.0, 423.4 → 367.3, 407.5 → 351.2, respectively. A good lin-
earity was found. Intra- and inter-day precision, accuracy, extraction recovery, matrix effect and stability
were validated to be within an acceptable range. The developed method was successfully applied to a
pharmacokinetic study after intravenous administration of a 10 mg/kg dose of PGB to rats.
